Surgical and pathologic predictors of recurrence and survival after neoadjuvant chemoimmunotherapy and resection for non–small cell lung cancer
作者
Peter J. Kneuertz,Hadrien Maréchal,Nasser Khaled Altorki,Nestor R. Villamizar,Joseph D. Phillips,Dan Jones,Shane Scott,Theodore Dimitrov,Philipp Schnorr,Desmond M. D’Souza,Ioana Baiu,Mahmoud Abdel‐Rasoul,Joachim G. H. Schmidt,Dao Nguyen,Jean‐Marc Baste,Robert E. Merritt
出处
期刊:JTCVS open [Elsevier BV] 日期:2026-09-01卷期号:: 102117-102117
Objective To evaluate long-term outcomes after neoadjuvant chemoimmunotherapy (chemo-IO) for non–small cell lung cancer and define the relative impact of surgical and pathologic factors on recurrence and survival. Methods Data from six centers in the US, France and Germany were combined for patients undergoing resection after neoadjuvant chemo-IO between 2019–2025. Recurrence patterns and survival were analyzed by surgical approach, extent of resection, perioperative outcomes, and pathologic response. Kaplan–Meier and Cox regression models identified factors associated with recurrence-free survival (RFS) and overall survival (OS). Results Among 320 patients, estimated 3-year RFS and OS were 69% (95%CI, 62–76%) and 82% (95%CI, 76–88%). Minimally-invasive surgery (robotic/VATS) was used in 86%, and lobectomy was performed in 85%. A pathologic complete response occurred in 36% and was associated with excellent outcomes (3-year OS 96%). Recurrence was observed in 70 patients (21.9%), including 27 (8.5%) locoregional and 41 (12.9%) distant events. Risk increased with residual viable tumor (<5%: 13%, 5–40%: 22.5%, >40%: 35.1%; p=0.001), nodal disease (40.7% vs. 16%; p<0.001), and positive margins (58.8% vs. 19.8%; p<0.001). Sublobar resection was associated with worse RFS (HR 3.3, 95%CI, 1.4–7.7). Open surgery (HR 3.0, 95%CI, 1.5–6.1) and major complications (HR 2.6, 95%CI, 1.3–5.2) were associated with worse OS, whereas pathologic stage remained the strongest predictor. Conclusions Long-term outcomes after neoadjuvant chemo-IO are primarily driven by pathologic response. The association between open surgery and worse survival likely reflects higher residual disease burden, whereas increased recurrence after sublobar resection warrants further investigation.